Free Trial

Novavax (NVAX) SEC Filings & 10K Form

Novavax logo
$5.60 -0.38 (-6.35%)
Closing price 04:00 PM Eastern
Extended Trading
$5.62 +0.02 (+0.27%)
As of 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Novavax SEC Filings

DateFilerForm TypeView
04/02/2025
1:52 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
7:03 PM
Novavax (Issuer)
Shiver John W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
7:04 PM
Novavax (Issuer)
Shiver John W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:33 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:34 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:30 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:03 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:04 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:07 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:39 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:42 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:43 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:46 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:01 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
7:05 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:41 AM
Novavax (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2025
6:04 PM
MCGLYNN MARGARET G (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:06 PM
Alton Gregg H (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Novavax (Subject)
Form SCHEDULE 13G/A
01/27/2025
5:19 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:50 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
4:41 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:52 PM
Novavax (Issuer)
Rodgers Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:44 PM
Novavax (Issuer)
YOUNG JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:47 PM
King Rachel K. (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:02 PM
Novavax (Subject)
YOUNG JAMES F (Reporting)
Form 144/A
12/30/2024
4:27 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
9:31 AM
Novavax (Subject)
YOUNG JAMES F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
4:24 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:24 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
11:13 AM
King Rachel K. (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2024
5:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:05 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
3:08 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:21 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:01 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:19 PM
Novavax (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:08 PM
Dubovsky Filip (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:47 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
4:06 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Secret Weapon (Ad)

Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.

Get Your FREE Presidential Transition Guide Today
08/08/2024
7:04 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:37 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
5:16 AM
Novavax (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
06/20/2024
4:08 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:35 PM
Novavax (Subject)
SK Bioscience Co., Ltd. (Filed by)
Form SC 13G/A
06/06/2024
6:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
8:35 PM
Novavax (Filer)
Form DEFA14A
05/20/2024
1:42 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/20/2024
5:09 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/15/2024
8:15 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
1:39 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:05 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:53 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
4:21 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
1:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/06/2024
3:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/06/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form PREC14A
04/29/2024
6:58 AM
Novavax (Filer)
Form DEFA14A
04/29/2024
7:01 AM
Novavax (Filer)
Form ARS
04/29/2024
6:54 AM
Novavax (Filer)
Form DEF 14A
04/15/2024
11:18 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
04/15/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:NVAX) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners